As IL-6 is also known as a key inflammatory mediator during cytokine storm in sepsis [2], further investigation of a possible impact of Ruxolitinib, JAK1 and IL-6 in RNase1-associated EC dysfunction might be of future interest. The gene discussed is JAK1; the disease is Sepsis.